250 related articles for article (PubMed ID: 12905686)
1. [Vaccination of rhesus monkeys with recombinant antigen fragments and protection from hepatitis E virus infection].
Ma YB; Xie TH; Zhang GM; Li CH; Dai XJ; Dai CB; Sun MS; Lu J; Bi SL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):592-5. PubMed ID: 12905686
[TBL] [Abstract][Full Text] [Related]
2. Cross-protection of hepatitis E virus genotypes 1 and 4 in rhesus macaques.
Huang W; Zhang H; Harrison TJ; Lang S; Huang G; Wang Y
J Med Virol; 2008 May; 80(5):824-32. PubMed ID: 18360896
[TBL] [Abstract][Full Text] [Related]
3. [The immuno-protect study of a hepatitis E virus ORF2 peptide expressed in E. coli].
Ge S; Zhang J; Huang G; Pang S; Zhou K; Xia N
Wei Sheng Wu Xue Bao; 2003 Feb; 43(1):35-42. PubMed ID: 16276869
[TBL] [Abstract][Full Text] [Related]
4. Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes.
Arankalle VA; Lole KS; Deshmukh TM; Srivastava S; Shaligram US
Vaccine; 2009 Feb; 27(7):1032-9. PubMed ID: 19095027
[TBL] [Abstract][Full Text] [Related]
5. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus.
Zhou YH; Purcell RH; Emerson SU
Vaccine; 2005 May; 23(24):3157-65. PubMed ID: 15837215
[TBL] [Abstract][Full Text] [Related]
6. Rhesus monkeys infected with hepatitis E virus (HEV) from the former USSR are immune to subsequent challenge with an Indian strain of HEV.
Arankalle VA; Favorov MO; Chadha MS; Phule DM; Banerjee K
Acta Virol; 1993 Dec; 37(6):515-8. PubMed ID: 8010189
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4.
Huang WJ; Zhang HY; Harrison TJ; Lan HY; Huang GY; Wang YC
Arch Virol; 2009; 154(3):481-8. PubMed ID: 19240977
[TBL] [Abstract][Full Text] [Related]
8. [Primary evaluation of anti-HEV diagnostic reagent by experimental infection animal model with hepatitis E virus].
Zhou C; Huang WJ; Wu X; Lan HY; Gu WJ; Huang GY; Zhang HY; Qi ZB; Li HM
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jan; 29(1):48-51. PubMed ID: 18785478
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary evidence that a hepatitis E virus (HEV) ORF2 recombinant protein protects cynomolgus macaques against challenge with wild-type HEV].
Bi S; Lu J; Jiang L; Huang G; Pan H; Jiang Y; Zhang M; Shen X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Mar; 16(1):31-2. PubMed ID: 11986741
[TBL] [Abstract][Full Text] [Related]
10. Varying abilities of recombinant polypeptides from different regions of hepatitis E virus ORF2 and ORF3 to detect anti-HEV immunoglobulin M.
Ma H; Song X; Li Z; Harrison TJ; Zhang H; Huang W; Hao W; Kong W; Wang Y
J Med Virol; 2009 Jun; 81(6):1052-61. PubMed ID: 19382255
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and efficacy of a bacterially expressed HEV ORF3 peptide, assessed by experimental infection of primates.
Ma H; Song X; Harrison TJ; Li R; Huang G; Zhang H; Kong W; Wang Y
Arch Virol; 2009; 154(10):1641-8. PubMed ID: 19763777
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection.
Kamili S; Spelbring J; Carson D; Krawczynski K
J Infect Dis; 2004 Jan; 189(2):258-64. PubMed ID: 14722891
[TBL] [Abstract][Full Text] [Related]
13. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model.
Zhang J; Ge SX; Huang GY; Li SW; He ZQ; Wang YB; Zheng YJ; Gu Y; Ng MH; Xia NS
J Med Virol; 2003 Dec; 71(4):518-26. PubMed ID: 14556264
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of human (genotype 1) and swine (genotype 4)-ORF2-based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections.
Arankalle VA; Lole KS; Deshmukh TM; Chobe LP; Gandhe SS
J Viral Hepat; 2007 Jun; 14(6):435-45. PubMed ID: 17501765
[TBL] [Abstract][Full Text] [Related]
16. A preliminary study on immune response to hepatitis E virus DNA vaccine in mice.
Lu F; Zhuang H; Zhu Y; Zhu X
Chin Med J (Engl); 1996 Dec; 109(12):919-21. PubMed ID: 9275321
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis E virus ORF3 antigens derived from genotype 1 and 4 viruses are detected with varying efficiencies by an anti-HEV enzyme immunoassay.
Ma H; Song X; Harrison TJ; Zhang H; Huang W; Wang Y
J Med Virol; 2011 May; 83(5):827-32. PubMed ID: 21360543
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
[TBL] [Abstract][Full Text] [Related]
19. [Establishment and application of reverse transcription-nested polymerase chain reaction for detection of hepatitis E RNA in serum].
Zhu X; Zhuang H; Zhu W
Zhonghua Yu Fang Yi Xue Za Zhi; 1996 Nov; 30(6):334-6. PubMed ID: 9388906
[TBL] [Abstract][Full Text] [Related]
20. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells.
Robinson RA; Burgess WH; Emerson SU; Leibowitz RS; Sosnovtseva SA; Tsarev S; Purcell RH
Protein Expr Purif; 1998 Feb; 12(1):75-84. PubMed ID: 9473460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
